# LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment

> **NCT04999423** · — · ACTIVE_NOT_RECRUITING · sponsor: **Microvention-Terumo, Inc.** · enrollment: 206 (actual)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DEVICE:** LVIS EVO and HydroCoil Embolic System

## Key facts

- **NCT ID:** NCT04999423
- **Lead sponsor:** Microvention-Terumo, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-14
- **Primary completion:** 2025-03-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04999423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04999423, "LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04999423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*